PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting

19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are now ...

Read more →

Drug Utilisation Sub-Committee outcome statement

17 July 2019 - The outcome statement from the June 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Drug Utilisation Sub-Committee utilisation analysis public release documents

12 July 2019 - The utilisation analysis public release documents from the February 2019 Drug Utilisation Sub-Committee Meeting are now available. ...

Read more →

Institute for Clinical and Economic Review lists potential topics for assessments in 2020

9 July 2019 - The Institute for Clinical and Economic Review has released its preliminary list of potential assessment topics ...

Read more →

PBAC Public Summary Documents - March 2019 meeting

5 July 2019 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2019 PBAC ...

Read more →

Call for all sponsors to publish clinical trial results in EU database

3 July 2019 - The European Commission, the European Medicines Agency and the Heads of Medicines Agencies have co-signed a ...

Read more →

Recommendations made by the PBAC - May 2019 intracycle meeting

28 June 2019 - The Department of Health has published an update of the outcomes from the May 2019 PBAC ...

Read more →

Should the FDA disclose new filings for drugs, biologics and biosimilars?

11 June 2019 - In 2010, the FDA issued draft recommendations on increasing the transparency of the FDA’s processes and ...

Read more →

Hiding in plain sight: the FDA’s approach to disclosing new drug applications is a disservice to public health

4 June 2019 - Remember in high school when a friend told you a secret and you guarded it assiduously, ...

Read more →

Consultation on draft guideline on quality requirements for medical devices in combination products

3 June 2019 - EMA has released a draft guideline on the quality requirements for medical devices in human medicines ...

Read more →

Prices of Canadian generic medicines below international average

29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...

Read more →

EMA publishes agenda for 27-29 2019 May CHMP meeting

27 May 2019 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

Breast cancer treatments, rare disorders, venlafaxine

27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...

Read more →

Asthma Stakeholder Meeting December 2018 – outcome statement

22 May 2019 - The outcome statement for the severe asthma stakeholder meeting held on 14 December 2018 is now available. ...

Read more →

Official Information Act response: adrenaline auto-injector cost utility analysis

20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...

Read more →